NCT05956405

Brief Summary

Prolonged COVID, also known as post-COVID or Sar-CoV-2 infection with post-acute sequelae, refers to a set of multi-organ symptoms that persist in patients who have suffered SARS-CoV-2 infection, even after of the acute phase of the disease. Approximately 10% of people experience this set of symptoms after their acute COVID has resolved. Such symptoms may include respiratory problems, myalgia, extreme fatigue, moodiness, cognitive impairment, and difficulty sleeping. Psychological therapies, such as mindfulness, have already demonstrated their effectiveness in pathologies of this type, improving mental health and physical function, as well as reinforcing acceptance and reducing symptoms. Specifically, amygdala-insula training was originally designed for patients with chronic fatigue syndrome as a method of reducing chronic over-sensitization and heightened fear response of the amygdala, which may be behind some of the symptoms related to both with this pathology as with fibromyalgia. A lot of research is currently being done on different types of treatments such as pharmaceutical, biological, dietary, homeopathic and rehabilitation for the treatment of persistent COVID; however, an effective treatment has not yet been found. Therefore, this study aims to evaluate the impact of a retraining intervention of the amygdala and insula for the improvement of the quality of life of patients with persistent COVID.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 20, 2023

Completed
1 day until next milestone

First Posted

Study publicly available on registry

July 21, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

September 1, 2023

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2024

Completed
Last Updated

September 16, 2025

Status Verified

September 1, 2025

Enrollment Period

7 months

First QC Date

July 20, 2023

Last Update Submit

September 10, 2025

Conditions

Outcome Measures

Primary Outcomes (6)

  • Short Form de 36 items (SF-36)

    In the AIR + Mindfulness program group

    Baseline

  • Short Form de 36 items (SF-36)

    In the AIR + Mindfulness program group

    Post-treatment 8 weeks from baseline

  • Short Form de 36 items (SF-36)

    In the AIR + Mindfulness program group

    Three-months follow-up

  • Short Form de 36 items (SF-36)

    In the relaxation program group

    Baseline

  • Short Form de 36 items (SF-36)

    In the relaxation program group

    Post-treatment 8 weeks from baseline

  • Short Form de 36 items (SF-36)

    In the relaxation program group

    Three-months follow-up

Secondary Outcomes (62)

  • Sociodemographic data Gender, age, marital status, education, occupation, economical level

    Baseline

  • Sociodemographic data Gender, age, marital status, education, occupation, economical level

    Baseline

  • Spanish Chronic Pain Grading Scale

    Baseline

  • Spanish Chronic Pain Grading Scale

    Baseline

  • Spanish Chronic Pain Grading Scale

    Post-treatment 8 weeks from baseline

  • +57 more secondary outcomes

Study Arms (2)

Amygdala & Insula Retraining + Mindfulness

EXPERIMENTAL
Behavioral: AIR + Mindfulness

Relaxation condition

ACTIVE COMPARATOR
Behavioral: Relaxation condition

Interventions

AIR + Mindfulness program consists of 8 sessions of 120 minutes/session (10-12 people) Written material and sound recordings will be offered as support elements. The estimated duration of the program is two months.

Amygdala & Insula Retraining + Mindfulness

Relaxation program consists of 8 sessions of 120 minutes/session (10-12 people) Written material and sound recordings will be offered as support elements. The estimated duration of the program is two months.

Relaxation condition

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age: 18-30 years old.
  • Grant informed consent.
  • Diagnosis of persistent COVID by primary care physicians.

You may not qualify if:

  • Age: \<18 years old
  • Serious medical or psychiatric illnesses

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Psychiatry. Miguel Servet University Hospital

Zaragoza, 50009, Spain

Location

Related Publications (1)

  • Gasion V, Barcelo-Soler A, Beltran-Ruiz M, Hijar-Aguinaga R, Camarero-Grados L, Lopez-Del-Hoyo Y, Garcia-Campayo J, Montero-Marin J. Effectiveness of an amygdala and insula retraining program combined with mindfulness training to improve the quality of life in patients with long COVID: a randomized controlled trial protocol. BMC Complement Med Ther. 2023 Nov 9;23(1):403. doi: 10.1186/s12906-023-04240-0.

MeSH Terms

Interventions

AirMindfulness

Intervention Hierarchy (Ancestors)

AtmosphereEnvironmentEcological and Environmental PhenomenaBiological PhenomenaMeteorological ConceptsEnvironment and Public HealthCognitive Behavioral TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 20, 2023

First Posted

July 21, 2023

Study Start

September 1, 2023

Primary Completion

March 31, 2024

Study Completion

March 31, 2024

Last Updated

September 16, 2025

Record last verified: 2025-09

Locations